(CIDRAP News) If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.
(CIDRAP News) A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergencyprompted in part by last fall's delays in delivery of the pandemic H1N1 vaccineis due to get under way in the next few weeks with a pair of conferences.
(CIDRAP News) Lobbying by the maker of the only US-licensed anthrax vaccine was a key factor in causing the federal government to cancel its big contract with VaxGen Inc. for a new anthrax vaccine that was expected to be safer, according to a report published yesterday by the Los Angeles Times.
(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.
(CIDRAP News) The federal government awarded two contracts totaling more than $150 million this week for further testing and initial production of new anthrax vaccines designed to be safer and require fewer doses than the existing vaccine.
(CIDRAP News) – The US Department of Health and Human Services yesterday announced $350 million in grants for eight regional centers to lead and coordinate research on defenses against bioterrorism and emerging infectious diseases.
(CIDRAP News) Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.